Industry / India
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
GE Healthcare Life Sciences Targets High Growth
May 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
To counter a 'lull' in US and Western Europe sales, GE Healthcare Life Sciences is targeting significantly increased demand in India for its tools that aid drug discovery. Over the coming year, the company is expecting 30% growth and hopes to capture a greater share of the US$400mn Indian bio-supplies sector. Given the advanced product range assembled by GE Healthcare Life Sciences and a planned increase in headcount, BMI believes that the company is well placed to achieve its